The world of diabetes and weight management is evolving at a breathtaking pace. While dual-action drugs like tirzepatide (Mounjaro) are making headlines, another powerful combination is on the horizon: CagriSema, which combines the well-known GLP-1 agonist semaglutide with a new drug called cagrilintide. What is Cagrilintide? Cagrilintide is a long-acting amylin analogue. Amylin is a…
